Saudi Cultural Missions Theses & Dissertations
Permanent URI for this communityhttps://drepo.sdl.edu.sa/handle/20.500.14154/10
Browse
2 results
Search Results
Item Restricted Investigation of a Low Sulphated Heparan Sulphate Mimetic for CNS Repair in an Animal Model of Demyelination(University of Glasgow, 2024-08-05) Zubair, Jood; Lindsay, SusanCentral nervous system (CNS) diseases, which include multiple sclerosis (MS), pose significant challenges due to their complex pathology and impact on patient quality of life. This investigation assesses the therapeutic potential of LS-mHep7, a low-sulphated heparan sulphate mimetic, using the cuprizone-induced demyelination model, which mimics MS characteristics such as demyelination, astrocyte reactivity, and microglia activation. Mice received cuprizone diet for five weeks to induce demyelination, followed by a two-week treatment with LS-mHep7 or PBS. Immunohistochemical analysis of brain sections was performed using markers for myelin (PLP), astrocytes (GFAP), and microglia (IBA-1). In vitro experiments investigated the effects of LS-mHep7 on microglia morphology, proliferation, and reactivity, using GM-CSF as an activator. In vivo experiments revealed that LS-mHep7 did not significantly improved PLP staining in the corpus callosum compared to PBS-treated mice, indicating that the treatment did not improve remyelination within the twoweek timeframe. Moreover, LS-mHep7 did not significantly reduce astrocyte reactivity or microglia activation, as seen by GFAP and IBA-1 staining. In vitro experiments demonstrated that LS-mHep7 had no significant effect on microglial morphology or GM-CSF-induced reactivity. While LS-mHep7 showed potential for promoting remyelination previously in vitro, it did not have any effect in this in vivo investigation nor did it effect glial reactivity. More accurate results may be obtained by optimizing approaches to treatment and using alternative quantification methods. Future studies should investigate different dosages, treatment durations, and combination therapies to improve LS-mHep7's efficacy in CNS repair.10 0Item Restricted Olfactory Mesenchymal Stromal Cells: A Potential Therapeutic Approach for Central Nervous System Repair(University of Glasgow, 2024) Alamoudi, Wesal; Lindsay, SusanMultiple sclerosis (MS) is an autoimmune mediated demyelinating disease that occurs in the central nervous system (CNS). The loss of myelin creates a disturbance in the flow of the electrical signals in the nerve cells leading to a range of neurological symptoms. Currently, only the inflammatory component is managed with no cure for the disease itself. A possible therapeutic approach is stem-cell based therapies. Bone marrow derived mesenchymal stromal cells (BM-MSCs) have been considered, but have limitations in promoting myelination. A newer approach is to utilize olfactory mucosa-derived MSCs (OM-MSCs) since they exist in a neurogenetic niche and provide more myelination enhancement. In this investigation, an in vitro and in vivo comparison of BM-MSCs and OM-MSCs was undertaken. OM-MSC condition media (CM) showed significant outcomes regarding OPC differentiation and the promotion of myelination in vitro. In the animal model of MS, experimental autoimmune encephalomyelitis (EAE), OM-MSC transplanted animals had reduced inflammation, myelin loss and astrocyte reactivity unlike BM-MSCs. This study also investigated the effect of OM-MSC-CM on IL-16-induced astrocyte reactivity in vitro. However, there was no significant effect. Taken together, our findings suggest that OM-MSCs should be considered as a therapeutic candidate to promote myelin repair in MS.16 0